A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes

Zucchini, S.; Scaramuzza, A. E.; Bonfanti, R.; Buono, P.; Cardella, F.; Cauvin, V.; Cherubini, V.; Chiari, G.; D'Annunzio, G.; Frongia, A. P.; Iafusco, D.; Maltoni, G.; Patera, I. P.; Toni, S.; Tumini, S.; Rabbone, I.; Lera, R.; Bobbio, A.; Gualtieri, A.; Piccinno, E.; Zecchino, C.; Pasquino, B.; Felappi, B.; Prandi, E.; Gallo, F.; Morganti, G.; Ripoli, C.; Cardinale, G.; Ponzi, G.; Castaldo, V.; Stamati, F.; Lo Presti, D.; Tomaselli, L.; Citriniti, F.; Suprani, T.; Bensa, M.; Graziani, V.; De Berardinis, F.; Chiarelli, F.; De Marco, R.; Lazzaro, N.; De Donno, V.; Banin, P.; Piccini, B.; Lenzi, L.; Mainetti, B.; Coccioli, M. S.; Minuto, N.; Lorini, R.; Trada, M.; Sogno Valin, P.; Beccaria, L.; Lucchesi, S.; Bruzzese, M.; Mammì, F.; Cirillo, D.; Pardi, D.; Taccardi, R. A.; Lombardo, F.; Zuccotti, G. V.; Meschi, F.; Iughetti, L.; Predieri, B.; Franzese, A.; Mozzillo, E.; Prisco, F.; Cadario, F.; Savastio, S.; Piredda, G.; Monciotti, C.; Galderisi, A.; Salvo, C.; Calcaterra, V.; Berioli, M. G.; Federico, G.; Favia, A.; Zanette, G.; Marsciani, A.; Schiaffini, R.; Cappa, M.; Delvecchio, M.; Gaiero, A.; Ignaccolo, G.; Cerutti, F.; Fontana, F.; Guerraggio, L.; Zonca, S.; Franceschi, R.; Tornese, G.; Biagioni, M.; Salvatoni, Alessandro; Cardani, R.; Marigliano, M.; Sabbion, A.; Maffeis, C.; Schieven, E.; Arnaldi, C.

doi:10.1155/2016/5719470

Abstract Background and aims: Evaluation of incidence and correlates of severe hypoglycemia (SH) and diabetes ketoacidosis (DKA) in children and adolescents with T1DM. Methods and results: Retrospective study conducted in 29 diabetes centers from November 2011 to April 2012. The incidence of SH and DKA episodes and their correlates were assessed through a questionnaire administered to parents of patients aged 0e18 years. Incidence rates and incident rate ratios (IRRs) were estimated through multivariate Poisson regression analysis and multilevel analysis. Overall, 2025 patients were included (age 12.4 3.8 years; 53% males; diabetes duration 5.6 3.5 years; HbA1c 7.9 1.1%). The incidence of SH and DKA were of 7.7 and 2.4 events/100 py, respectively. The risk of SH was higher in females (IRR Z 1.44; 95%CI 1.04e1.99), in patients using rapid acting analogues as compared to regular insulin (IRR Z 1.48; 95%CI 0.97e2.26) and lower for patients using long acting analogues as compared to NPH insulin (IRR Z 0.40; 95% CI 0.19e0.85). No correlations were found between SH and HbA1c levels. The risk of DKA was higher in patients using rapid acting analogues (IRR Z 4.25; 95%CI 1.01e17.86) and increased with insulin units needed (IRR Z 7.66; 95%CI 2.83e20.74) and HbA1c levels (IRR Z 1.63; 95% CI 1.36 e1.95). Mother’s age was inversely associated with the risk of both SH (IRR Z 0.95; 95%CI 0.92e0.98) and DKA (IRR Z 0.94; 95%CI 0.88e0.99). When accounting for center effect, the risk of SH associated with the use of rapid acting insulin analogues was attenuated (IRR Z 1.48; 95%CI 0.97e2.26); 33% and 16% of the residual variance in SH and DKA risk was explained by center effect. Conclusion: The risk of SH and DKA is mainly associated with treatment modalities and strongly depends on the practice of specialist centers.

We conducted a retrospective survey in pediatric centers belonging to the Italian Society for Pediatric Diabetology and Endocrinology. The following data were collected for all new-onset diabetes patients aged 0-18 years: DKA (pH < 7.30), severe DKA (pH < 7.1), DKA in preschool children, DKA treatment according to ISPAD protocol, type of rehydrating solution used, bicarbonates use, and amount of insulin infused. Records (n = 2453) of children with newly diagnosed diabetes were collected from 68/77 centers (87%), 39 of which are tertiary referral centers, the majority of whom (n = 1536, 89.4%) were diagnosed in the tertiary referral centers. DKA was observed in 38.5% and severe DKA in 10.3%. Considering preschool children, DKA was observed in 72%, and severe DKA in 16.7%. Cerebral edema following DKA treatment was observed in 5 (0.5%). DKA treatment according to ISPAD guidelines was adopted in 68% of the centers. In the first 2 hours, rehydration was started with normal saline in all centers, but with different amount. Bicarbonate was quite never been used. Insulin was infused starting from third hour at the rate of 0.05-0.1 U/kg/h in 72% of centers. Despite prevention campaign, DKA is still observed in Italian children at onset, with significant variability in DKA treatment, underlying the need to share guidelines among centers.